beta-catenin modulator (Emory University)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namebeta-catenin modulator (Emory University)
Drug Alias Namebeta-catenin modulator (Emory University)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCatenin beta 1 modulators
TargetsCatenin beta 1
Therapy Area/IndicationsAdenomatous Polyposis Coli
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEmory University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEmory University
Active IndicationsN/A
Inactive IndicationsAdenomatous Polyposis Coli

Other Information

ATC CodeN/A
Related LinksN/A